← Back to headlines
Bayer's Experimental PET Tracer Demonstrates Accuracy in Phase 3 Cardiac Amyloidosis Trial
Bayer reported positive Phase 3 trial results for an experimental PET imaging tracer, showing high diagnostic accuracy for cardiac amyloidosis. The findings support further development of the imaging agent for detecting this heart condition.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
